(IDME) International Drawdown - Ratings and Ratios
International Equity ETFs, Equity-Linked Notes
Dividends
| Dividend Yield | 5.18% |
| Yield on Cost 5y | 5.72% |
| Yield CAGR 5y | 37.21% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 11.0% |
| Value at Risk 5%th | 18.0% |
| Relative Tail Risk | -0.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.79 |
| Alpha | 18.32 |
| CAGR/Max DD | 1.04 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.357 |
| Beta | 0.591 |
| Beta Downside | 0.549 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.88% |
| Mean DD | 2.31% |
| Median DD | 1.68% |
Description: IDME International Drawdown December 29, 2025
The International Drawdown Managed Equity ETF (BATS: IDME) is an actively managed fund that blends two core components: a “Equity Strategy” that allocates the bulk of assets to other ETFs holding non-U.S. stocks across developed and emerging markets, and an “ELN Strategy” that invests the remainder in equity-linked notes to generate supplemental income. Because it relies heavily on derivative-based ELNs, the fund is classified as non-diversified and carries additional credit- and currency-risk relative to a pure equity ETF.
Key quantitative points (as of the most recent filing) include an expense ratio of roughly 0.85 % and assets under management near $200 million, with an annualized distribution yield of about 5 % driven largely by the ELN component. The fund’s performance is closely tied to global growth trends-especially emerging-market GDP growth and commodity demand-while rising U.S. interest rates can compress the income generated by ELNs and increase the cost of hedging foreign-currency exposure.
For a deeper, data-driven look at IDME’s risk-adjusted returns and scenario analysis, the ValueRay platform provides granular back-test results that can help you assess whether its hybrid strategy aligns with your portfolio objectives.
What is the price of IDME shares?
Over the past week, the price has changed by +0.92%, over one month by +5.35%, over three months by +9.47% and over the past year by +34.98%.
Is IDME a buy, sell or hold?
What are the forecasts/targets for the IDME price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 29.6 | 17.1% |
IDME Fundamental Data Overview January 10, 2026
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 407.0m USD (407.0m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 407.0m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 407.0m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.09% (E(407.0m)/V(407.0m) * Re(8.09%) + (debt-free company))
Discount Rate = 8.09% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IDME ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle